#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Progressive multifocal leukoencephalopathy Haemolytic uraemic syndrome Wolfram syndrome Anti-neutrophil cytoplasmic antibody positive vasculitis Oropharyngeal cancer recurrent Spinal muscular atrophy Ductal adenocarcinoma of pancreas Cardiomyopathy Nephroblastoma Acute graft versus host disease in skin Follicular lymphoma stage III Glycogen storage disease type V Chronic cutaneous lupus erythematosus Mantle cell lymphoma stage II Ichthyosis More trials…

    Learn about Rare Diseases

    Glycogen storage disease type II Skin angiosarcoma Malignant fibrous histiocytoma – Trials in Disease Chordoma – Trials in Disease Usher’s syndrome – Diagnostics Sarcoidosis – Life with Disease Encephalitis autoimmune – Life with Disease Lymphatic malformation – Life with Disease Friedreich’s ataxia – Diagnostics Alexander disease – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Metformin Bomedemstat Paroxetine GRAPHITE Relatlimab Pimavanserin Tartrate GLYCYL-TYROSINE NVG-2089 Water For Injection Datopotamab Deruxtecan Polydextrose IPN01195 ANOC-001 Posaconazole RNK001 Ads-010 Lisinopril Pf-06835375 Azd5462 Defactinib More therapies…

    Learn about Your Condition

    Notalgia paraesthetica Paedophilia Adenocarcinoma gastric Endometrial cancer stage I Coeliac disease Renal injury Haemodynamic instability Primary hypogonadism Myocarditis post infection Small intestine carcinoma Hyponatraemia Renal cell carcinoma Status epilepticus Familial hypertriglyceridaemia Neuromyopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of AZD6793 tablets to reduce flare-ups in adults with moderate to very severe chronic obstructive pulmonary disease (COPD)

    Recruiting

    2 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Bulgaria Denmark Germany Greece Hungary Italy +2

  • Study of oral BI 1815368 compared to placebo in patients with diabetic macular edema over 48 weeks of treatment

    Recruiting

    2 1
    Czechia Germany Hungary Poland Slovakia

  • Study of Everolimus and Resistance Training to Improve Bone Formation in Healthy Postmenopausal Women

    Recruiting

    2 1 1
    Investigated Diseases:
    • Osteoporosis postmenopausal
    Investigated Drugs:
    • Everolimus
    • Placebo
    Denmark

  • Study of LY3457263 compared to placebo in adults with type 2 diabetes who are taking semaglutide or tirzepatide but have not reached their blood sugar goals

    Recruiting

    2 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Tirzepatide
    Germany Poland

  • Comparing effectiveness of topical permethrin, oral ivermectin, and their combination for treating patients with confirmed scabies infection

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acarodermatitis
    Investigated Drugs:
    • Ivermectin
    Italy

  • Study of melphalan followed by trifluridine-tipiracil and bevacizumab combination versus trifluridine-tipiracil and bevacizumab in liver metastatic colorectal cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    • Colorectal cancer
    Investigated Drugs:
    • Tipiracil Hydrochloride
    • Tipiracil
    • Trifluridine
    Czechia Germany Italy The Netherlands Spain
Previous Page
1 … 136 137 138 139 140 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!